143 related articles for article (PubMed ID: 35640442)
1. Changes in diagnostic sensitivity, incidence and presentation of complete and partial hydatidiform mole over the years.
Aiob A; Naskovica K; Amdur Zilberfarb I; Sharon A; Bornstein J; Lowenstein L
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():136-141. PubMed ID: 35640442
[TBL] [Abstract][Full Text] [Related]
2. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center.
Fowler DJ; Lindsay I; Seckl MJ; Sebire NJ
Ultrasound Obstet Gynecol; 2006 Jan; 27(1):56-60. PubMed ID: 16273594
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.
Albright BB; Myers ER; Moss HA; Ko EM; Sonalkar S; Havrilesky LJ
Am J Obstet Gynecol; 2021 Nov; 225(5):513.e1-513.e19. PubMed ID: 34058170
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value and accuracy of ultrasound in diagnosing hydatidiform mole: A systematic review and meta-analysis of the literature.
Newhouse I; Spacey A; Scragg B; Szczepura K
Radiography (Lond); 2022 Nov; 28(4):897-905. PubMed ID: 35785640
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis.
Memtsa M; Johns J; Jurkovic D; Ross JA; Sebire NJ; Jauniaux E
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():206-212. PubMed ID: 32877774
[TBL] [Abstract][Full Text] [Related]
6. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.
Jiao L; Wang Y; Jiang J; Wang X; Zhang W; Zhu C; Xiang Y
Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419
[TBL] [Abstract][Full Text] [Related]
7. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
[TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
[TBL] [Abstract][Full Text] [Related]
9. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies.
Sebire NJ; Rees H; Paradinas F; Seckl M; Newlands E
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):662-5. PubMed ID: 11844211
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and diagnosis of early hydatidiform mole].
Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
[No Abstract] [Full Text] [Related]
13. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
[TBL] [Abstract][Full Text] [Related]
14. Sonographic appearance of first trimester complete hydatidiform moles.
Benson CB; Genest DR; Bernstein MR; Soto-Wright V; Goldstein DP; Berkowitz RS
Ultrasound Obstet Gynecol; 2000 Aug; 16(2):188-91. PubMed ID: 11117091
[TBL] [Abstract][Full Text] [Related]
15. Current clinical features of complete and partial hydatidiform mole in Sweden.
Joneborg U; Marions L
J Reprod Med; 2014; 59(1-2):51-5. PubMed ID: 24597287
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
17. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center.
Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS
J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955
[TBL] [Abstract][Full Text] [Related]
18. The accuracy of first trimester ultrasound in the diagnosis of hydatidiform mole.
Kirk E; Papageorghiou AT; Condous G; Bottomley C; Bourne T
Ultrasound Obstet Gynecol; 2007 Jan; 29(1):70-75. PubMed ID: 17201012
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
Stone M; Bagshawe KD
Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
[TBL] [Abstract][Full Text] [Related]
20. Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades.
Sun SY; Melamed A; Joseph NT; Gockley AA; Goldstein DP; Bernstein MR; Horowitz NS; Berkowitz RS
Int J Gynecol Cancer; 2016 Feb; 26(2):367-70. PubMed ID: 26588240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
